Discontinued — last reported Q3 '25
Common Stock
EquityEli Lilly Common Stock decreased by 0.1% to $591.40M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.4%, from $593.90M to $591.40M. Over 4 years (FY 2020 to FY 2024), Common Stock shows relatively stable performance with a -0.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2008
Last reportedQ3 2025
How to read this metric
Changes usually reflect new share issuances or the exercise of stock-based compensation, though for mature firms, this remains relatively static.
Detailed definition
The total par value of the shares issued by the corporation to its investors. This represents the legal capital of the c...
Peer comparison
Standard across all publicly traded entities; often analyzed alongside 'Additional Paid-in Capital'.
Metric ID:
common_stockHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $598.10M | $598.20M | $596.30M | $594.10M | $594.10M | $594.10M | $594.10M | $593.50M | $593.60M | $593.60M | $593.60M | $594.20M | $594.20M | $593.90M | $592.40M | $592.60M | $592.00M | $591.40M |
| QoQ Change | — | +0.0% | -0.3% | -0.4% | +0.0% | +0.0% | +0.0% | -0.1% | +0.0% | +0.0% | +0.0% | +0.1% | +0.0% | -0.1% | -0.3% | +0.0% | -0.1% | -0.1% |
| YoY Change | — | — | — | — | -0.7% | -0.7% | -0.4% | -0.1% | -0.1% | -0.1% | -0.1% | +0.1% | +0.1% | +0.1% | -0.2% | -0.3% | -0.4% | -0.4% |
Range$591.40M – $598.20M
CAGR-0.3%
Avg YoY Growth-0.2%
Median YoY Growth-0.2%
Current Streak2 quarters decline
Common Stock at Other Companies
Frequently Asked Questions
- What is Eli Lilly's common stock?
- Eli Lilly (LLY) reported common stock of $591.40M in Q3 2025.
- How has Eli Lilly's common stock changed year-over-year?
- Eli Lilly's common stock decreased by 0.4% year-over-year, from $593.90M to $591.40M.
- What is the long-term trend for Eli Lilly's common stock?
- Over 4 years (2020 to 2024), Eli Lilly's common stock has grown at a -0.2% compound annual growth rate (CAGR), from $598.20M to $592.40M.
- What does common stock mean?
- The base value of the shares the company has issued to its owners.